Primogene GmbH
PrivateLast Round
Seed
Apr 29, 2026
Total Funding Raised
$4.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Primogene GmbH operates in Healthcare & Life Sciences and is based in Leipzig. Its latest recorded funding round was a Seed round in April 2026.
Primogene GmbH is a biotechnology company that develops and manufactures high-quality, bioidentical functional ingredients using proprietary enzymatic platform technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Primogene GmbH Comparables
Compare Primogene GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zymtronix | 78% | |
| Glycosyn LLC | 78% | |
| Inbiose | 77% |
For institutional investors. Book with your work email.
Primogene GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Primogene GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| better ventures | Seed |
| Sächsische Beteiligungsgesellschaft | Seed |
| FS Life Science Investment | Seed |
| High-Tech Gründerfonds | Seed |
| TGFS | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 38% QoQ, from 8 to 11 employees.
- Jun 28, 2026
Grew 43% QoQ from 7 to 10 employees.
For institutional investors. Book with your work email.
Primogene GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Primogene GmbH's valuation, stock price, and market status.
Is Primogene GmbH a public or private company?
Primogene GmbH is a private company.
What is the current stock price of Primogene GmbH?
Primogene GmbH is a private company, so its shares have no public market price. Caplight tracks Primogene GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Primogene GmbH worth (valuation)?
Valuation information for Primogene GmbH is not publicly available.
Can I buy Primogene GmbH stock?
Primogene GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Primogene GmbH's last funding round?
Primogene GmbH's most recent funding round was Seed on April 29, 2026.
Who are the main investors in Primogene GmbH?
Key investors in Primogene GmbH include High-Tech Gründerfonds.
Will Primogene GmbH IPO soon?
No public IPO plans have been announced for Primogene GmbH.
How can I track Primogene GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Primogene GmbH's shares on secondary markets.